Pacific Center for Financial Services
Position in GILD — Gilead Sciences, Inc.
CIK 1698222
SAN RAMON, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$77,320
-$8,671 QoQ
Shares Held
612
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,023
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pacific Center for Financial Services holds $1,504,810 across 13 Drug Manufacturers - General names. GILD ranks #7 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,866 | $473,908 | |
| 2 | MRK |
Merck & Co., Inc.
|
2,026 | $260,341 | |
| 3 | ABBV |
AbbVie Inc.
|
935 | $235,283 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,757 | $158,858 | |
| 5 | PFE |
Pfizer Inc
|
4,775 | $114,982 | |
| 6 | AMGN |
Amgen Inc
|
264 | $95,599 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
612 | $77,320 | |
| 8 | AZN |
Astrazeneca PLC
|
175 | $33,183 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,320 | 612 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $85,991 | 617 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $74,134 | 604 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $67,044 | 604 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $66,632 | 601 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $67,117 | 599 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $55,052 | 596 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $49,717 | 593 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $40,411 | 589 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $42,851 | 585 | Shares | Sole | 2024-05-20 | |
| 2023-12-31 | $47,066 | 581 | Shares | Sole | 2024-02-20 | |
| 2023-09-30 | $43,315 | 578 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $44,238 | 574 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $47,375 | 571 | Shares | Sole | 2023-05-16 | |
| 2022-09-30 | $34,793 | 564 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $34,613 | 560 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $33,054 | 556 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $40,080 | 552 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $38,347 | 549 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $37,528 | 545 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $35,029 | 542 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $31,343 | 538 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $30,773 | 487 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $37,238 | 484 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $15,699 | 210 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||